Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
Teva, Allergan enter into $58m opioid settlement with San Francisco
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva reaches proposed $4.35 billion settlement of U.S. opioid lawsuits
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva Pharmaceuticals will pay $420 million in a federal case
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva may move court against Dr Reddy's for patent infringement | Mint
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
